Long-term oral antiarrhythmic therapy with mexiletine.

Forty-eight patients with ischaemic heart disease received oral mexiletine for the control or prevention of ventricular arrhythmias. The most frequently used doses were 200, 250, and 300 mg 8-hourly. The treatment period varied from 2 days to more than 1 year (median 3 months). No ventricular arrhyt...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Br Heart J
Principais autores:	Campbell, N P, Pantridge, J F, Adgey, A A
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMJ Publishing Group 1978
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC483486/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/687477/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/hrt.40.7.796
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!